US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ecopetrol SA

9.00

-0.5500-5.76%

Post-market: 8.96-0.0400-0.44%19:51 EDT

Volume:5.81M

Turnover:51.42M

Market Cap:18.50B

PE:5.46

High:9.14

Open:9.05

Low:8.55

Close:9.55

Loading ...

Overview Company News Filings

Ecopetrol SA expected to post earnings of 31 cents a share - Earnings Preview

Valneva Receives EMA’s Positive CHMP Opinion for Adolescent Label Extension for Chikungunya Vaccine IXCHIQ®

The Committee for Medicinal Products for Human Use (CHMP) Reaffirms Positive Opinion for Lecanemab in Early Alzheimer's Disease

The Committee for Medicinal Products for Human Use (CHMP) reaffirms positive opinion for Lecanemab in early Alzheimer's disease in the EU

Krystal Biotech's Skin Disorder Treatment Recommended by European Medicines Agency Committee

MT Newswires Live

Press Release: Krystal Biotech Receives Positive CHMP Opinion for VYJUVEK(R) for the Treatment of Dystrophic Epidermolysis Bullosa

Regulatory and Financial Challenges Loom for Aurinia Pharmaceuticals Despite FDA and EC Approvals

Press Release: Chemtrade Logistics Income Fund Announces Fourth Quarter and Full Year 2024 Financial Results

ICF Reports Fourth Quarter and Full Year 2024 Results

Moody's Maintains Ecopetrol's Global Credit Rating at Ba1 with a Stable Outlook

TG Therapeutics Announces Presentation of Data for BRIUMVI® in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum

Ligand Reports Fourth Quarter and Full Year 2024 Financial Results

BeiGene Announces Fourth Quarter and Full Year 2024 Financial Results and Business Updates

Ecopetrol (EC) Stock Slides as Market Rises: Facts to Know Before You Trade

TG Therapeutics to Host Conference Call on Fourth Quarter and Full Year 2024 Financial Results and Business Update

Rhythm Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Business Update

Stocks to watch: Great Eastern, FCT, Yangzijiang Financial, PropNex, EC World Reit

Almirall 2024 Full-Year Results: Almirall Surpassed Guidance for 2024 - Entering an Era of Sustained Growth and Further Advancing Its Medical Dermatology Pipeline

ECOPETROL S.A.: Call for General Shareholders' Meeting

Ecopetrol publishes measures to guarantee the adequate representation of its Shareholders at the Ordinary General Shareholders' Meeting to be held on March 28, 2025

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/EC/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"EC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EC\",,,,,undefined,":{"symbol":"EC","market":"US","secType":"STK","nameCN":"Ecopetrol SA","latestPrice":9,"timestamp":1743796800000,"preClose":9.55,"halted":0,"volume":5812255,"hourTrading":{"tag":"盘后","latestPrice":8.96,"preClose":9,"latestTime":"19:51 EDT","volume":15864,"amount":141377.7987,"timestamp":1743810672540},"delay":0,"floatShares":233421326,"shares":2055834734,"eps":1.647439,"marketStatus":"Closed","change":-0.55,"latestTime":"04-04 16:00:00 EDT","open":9.05,"high":9.14,"low":8.55,"amount":51415614.58785,"amplitude":0.06178,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":1.647439,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1744012800000},"marketStatusCode":5,"adr":1,"adrRate":20,"listingDate":1221710400000,"exchange":"NYSE","adjPreClose":9.55,"preHourTrading":{"tag":"盘前","latestPrice":9.06,"preClose":9.55,"latestTime":"09:29 EDT","volume":72371,"amount":646616.06854,"timestamp":1743773399369},"postHourTrading":{"tag":"盘后","latestPrice":8.96,"preClose":9,"latestTime":"19:51 EDT","volume":15864,"amount":141377.7987,"timestamp":1743810672540},"volumeRatio":1.971909,"impliedVol":0.8153,"impliedVolPercentile":0.9761},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EC\",,,,,undefined,":{"symbol":"EC","floatShares":233421326,"roa":"8.01%","roe":"18.41%","lyrEps":1.647439,"volumeRatio":1.971909,"shares":2055834734,"dividePrice":1.0404,"high":9.14,"amplitude":0.06178,"preClose":9.55,"low":8.55,"week52Low":7.21,"pbRate":"0.92","psRate":"0.58","week52High":12.67,"institutionHeld":0,"latestPrice":9,"eps":1.647439,"divideRate":0.1156,"volume":5812255,"delay":0,"ttmEps":1.647439,"open":9.05,"prevYearClose":7.92,"prevWeekClose":10.22,"prevMonthClose":10.44,"prevQuarterClose":10.44,"fiveDayClose":10.22,"twentyDayClose":9.92,"sixtyDayClose":8.55},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"EC\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2516302397","title":"Ecopetrol SA  expected to post earnings of 31 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2516302397","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516302397?lang=en_us&edition=fundamental","pubTime":"2025-03-01 05:46","pubTimestamp":1740779166,"startTime":"0","endTime":"0","summary":"Ecopetrol SA  expected to post earnings of31cents a share - Earnings Preview Ecopetrol SA EC.N, EC is expected to show a fall in quarterly revenue when it reports  results on March 4 for the period en","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250228:nL5N3PJ2ID:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EC"],"gpt_icon":0},{"id":"2516712473","title":"Valneva Receives EMA’s Positive CHMP Opinion for Adolescent Label Extension for Chikungunya Vaccine IXCHIQ®","url":"https://stock-news.laohu8.com/highlight/detail?id=2516712473","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516712473?lang=en_us&edition=fundamental","pubTime":"2025-03-01 00:45","pubTimestamp":1740761100,"startTime":"0","endTime":"0","summary":"If granted, IXCHIQ will become the first vaccine against the chikungunya virus  available in the EU for adolescents 12 years of age and older. Juan Carlos Jaramillo, M.D., Chief Medical Officer of Valneva, said, “Given the substantial risk that chikungunya presents to individuals residing in or traveling to endemic regions, it's imperative to ensure the vaccine is available to all age groups. Therefore, this positive CHMP opinion marks a crucial milestone toward introducing a more robust preventative solution against chikungunya in the EU. Broader accessibility will help provide protection and mitigate the burden of this debilitating illness, which is continuing to spread in areas that were previously unaffected.”The CHMP positive opinion follows four regulatory approvals in the U.S6., Europe7, Canada8 and the UK9 in adults 18 years of age and older. Valneva expects to receive marketing approval in Brazil in the first quarter of 2025, which would represent the first approval in an ende","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/valneva-receives-ema-positive-chmp-164500042.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","BK4135","INRLF","VALN","BK4201","CHMP","BK4087","BK4156","CEPI","BK4539","EC","SII"],"gpt_icon":0},{"id":"2514032464","title":"The Committee for Medicinal Products for Human Use (CHMP) Reaffirms Positive Opinion for Lecanemab in Early Alzheimer's Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2514032464","media":"PR Newswire","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514032464?lang=en_us&edition=fundamental","pubTime":"2025-02-28 21:23","pubTimestamp":1740748980,"startTime":"0","endTime":"0","summary":"TOKYO and CAMBRIDGE, Mass., Feb. 28, 2025 /PRNewswire/ -- Eisai Co., Ltd.  and Biogen Inc.  announced today that the Committee for Medicinal Products for Human Use  of the European Medicines Agency has reaffirmed its positive opinion by consensus for theanti-Aβ monoclonal antibody lecanemab, adopted in November 2024.1 Following CHMP's reaffirmation, after having considered the additional information requested by the European Commission , the EC will resume the decision-making process for lecanemab's marketing authorization.Lecanemabhas been approved in the U.S.,3Japan,4China,5South Korea,6 Hong Kong,7Israel,8the United Arab Emirates,9the United Kingdom,10 Mexico,11 Macau and Oman,and is under regulatory review in 18 countries and regions including the EU. In January2025,the U.S. Food and Drug Administration  has approved the Supplemental Biologics License Application  for once every four weeks maintenancedosing. In January2025, the submission of","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/committee-medicinal-products-human-chmp-132300937.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/committee-medicinal-products-human-chmp-132300937.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BIIB","BK4087","BK4585","BK4588","IE00B19Z9P08.USD","IE00B19Z9Z06.USD","LU0234570918.USD","BK4532","BK4533","CHMP","BK4201","BK4139","LU0109394709.USD","MCI","LU0889565916.HKD","IE00B894F039.SGD","EC","LU0320765992.SGD"],"gpt_icon":0},{"id":"2514623324","title":"The Committee for Medicinal Products for Human Use (CHMP) reaffirms positive opinion for Lecanemab in early Alzheimer's disease in the EU","url":"https://stock-news.laohu8.com/highlight/detail?id=2514623324","media":"PR Newswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514623324?lang=en_us&edition=fundamental","pubTime":"2025-02-28 21:12","pubTimestamp":1740748320,"startTime":"0","endTime":"0","summary":"STOCKHOLM, Feb. 28, 2025 /PRNewswire/ -- BioArctic AB's   partner Eisai today announced today that the Committee for Medicinal Products for Human Use  of the European Medicines Agency has reaffirmed its positive opinion for the anti-Aβ monoclonal antibody lecanemab , adopted in November 2024. Following CHMP's reaffirmation, after having considered the additional information requested by the European Commission , the EC will resume the decision-making process for lecanemab's marketing authorisation.If the EC approves the lecanemab marketing authorization application, the approval will apply to all 27 European Union member states, as well as Iceland, Liechtenstein, and Norway. Leqembi is already approved in the US, Japan, China, Great Britain and other markets. Eisai and BioArctic will continue to make every effort to deliver lecanemab to patients with early AD in as soon as possible.Lecanemab is approved in the U.S., Japan, China, United Kingdom, and several other markets for the treatm","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/committee-medicinal-products-human-chmp-131200104.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/committee-medicinal-products-human-chmp-131200104.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4087","CHMP","MCI","EC","BRCTF","BK4201","BK4139","BK4156"],"gpt_icon":0},{"id":"2514649329","title":"Krystal Biotech's Skin Disorder Treatment Recommended by European Medicines Agency Committee","url":"https://stock-news.laohu8.com/highlight/detail?id=2514649329","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514649329?lang=en_us&edition=fundamental","pubTime":"2025-02-28 21:01","pubTimestamp":1740747688,"startTime":"0","endTime":"0","summary":"Krystal Biotech  said Friday that the European Medicines Agency's Committee for Medicinal Products for Human Use has recommended European Commission  approval of Vyjuvek for the treatment of wounds in patients with dystrophic epidermolysis bullosa.The indication is specifically for patients with the genetic skin disorder who have mutations in the collagen type VII alpha 1 chain gene starting from birth, the company said.The opinion supports administration of the drug, also called beremagene geperpavec-svdt,  either at a clinic or at home by healthcare professionals or trained patients or caregivers, the company said.A final decision by the European Commission is expected in Q2, the company said.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["KRYS","BK4139","BK4201","MDCO","EC"],"gpt_icon":0},{"id":"2514326561","title":"Press Release: Krystal Biotech Receives Positive CHMP Opinion for VYJUVEK(R) for the Treatment of Dystrophic Epidermolysis Bullosa","url":"https://stock-news.laohu8.com/highlight/detail?id=2514326561","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514326561?lang=en_us&edition=fundamental","pubTime":"2025-02-28 20:40","pubTimestamp":1740746400,"startTime":"0","endTime":"0","summary":"Krystal Biotech Receives Positive CHMP Opinion for VYJUVEK for the Treatment of Dystrophic Epidermolysis Bullosa. EC approval decision anticipated in second quarter of 2025. PITTSBURGH, Feb. 28, 2025  -- Krystal Biotech, Inc.  , a commercial-stage biotechnology company, today welcomed the European Medicines Agency's  announcement that its Committee for Medicinal Products for Human Use  has issued a positive recommendation for the European Commission  to approve VYJUVEK  for the treatment of wounds in patients with dystrophic epidermolysis bullosa  who have mutations in the collagen type VII alpha 1 chain  gene, starting from birth. The CHMP's positive opinion includes support for administration of VYJUVEK in either a health care setting  or at home. If deemed appropriate by a healthcare professional, trained patients or caregivers may also apply VYJUVEK.The final EC decision is anticipated in the second quarter of 2025. The decision will be applicable to all European Union member state","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KRYS","BK4087","BK4232","BK4139","BK4201","BK4022","EC","R","CHMP"],"gpt_icon":0},{"id":"2514706394","title":"Regulatory and Financial Challenges Loom for Aurinia Pharmaceuticals Despite FDA and EC Approvals","url":"https://stock-news.laohu8.com/highlight/detail?id=2514706394","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514706394?lang=en_us&edition=fundamental","pubTime":"2025-02-28 14:00","pubTimestamp":1740722444,"startTime":"0","endTime":"0","summary":"Aurinia Pharmaceuticals (AUPH) has disclosed a new risk, in the Regulation category. Aurinia Pharmaceuticals faces significant regulatory risks des...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/regulatory-and-financial-challenges-loom-for-aurinia-pharmaceuticals-despite-fda-and-ec-approvals?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/regulatory-and-financial-challenges-loom-for-aurinia-pharmaceuticals-despite-fda-and-ec-approvals?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4201","BK4139","AUPH","EC"],"gpt_icon":0},{"id":"2514339989","title":"Press Release: Chemtrade Logistics Income Fund Announces Fourth Quarter and Full Year 2024 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2514339989","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514339989?lang=en_us&edition=fundamental","pubTime":"2025-02-28 13:01","pubTimestamp":1740718860,"startTime":"0","endTime":"0","summary":"Reiterates 2025 Guidance for Adjusted EBITDA of Between $430.0 Million and $460.0 Million. Revenue of $446.5 million, an increase of $24.5 million or 5.8%. year-over-year. Excluding $5.7 million in the prior year period related. to the P2S5 business sold in Q4 2023, revenue increased by $30.2 million. Adjusted EBITDA of $108.6 million, an increase of $23.9 million or. related to the P2S5 business sold in Q4 2023, Adjusted EBITDA increased. Net earnings of $10.3 million, a decrease of $1.4 million. year-over-year, primarily due to the gain on sale of the P2S5 business in. million, an increase of $26.0 million or 192.5% year-over-year.year-over-year. Excluding $40.3 million in the prior year period related. to the P2S5 business sold in Q4 2023 and a $10.5 million negative impact. Adjusted EBITDA in Chemtrade's history. Excluding the negative impacts in. was similar to the record level of Adjusted EBITDA generated during. year-over-year, due to higher net finance costs, unrealized foreign","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CGIFF","NEX.SI","BK6520","BK6039","BK4201","SWC","BK4090","EC"],"gpt_icon":0},{"id":"2514582963","title":"ICF Reports Fourth Quarter and Full Year 2024 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2514582963","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514582963?lang=en_us&edition=fundamental","pubTime":"2025-02-28 05:05","pubTimestamp":1740690300,"startTime":"0","endTime":"0","summary":"―Fourth Quarter Results Led by Strong Demand From Commercial Energy Clients―。―Full Year Profitability Gains Driven By Favorable Mix, Higher Utilization and Lower Interest Expense―。―Recent Acquisition Expands ICF's Capabilities to Serve Utility and State & Local Government Clients―。―Repurchased 395,000 Shares From Mid-November 2024 To-date―。―Provides Framework for Full Year 2025 and First Quarter 2025 Guidance―。Net Income Was $24.6 Million, Up 11%; GAAP EPS Was $1.30, Up 12%, Inclusive of $0.23 Per Share in Tax-Effected Special Charges. EBITDA1 Was $50.8 Million; Adjusted EBITDA1 Was $56.3 Million. Net Income Was $110 Million, Up 33%; Diluted EPS Was $5.82, Up 34%, Inclusive of $0.24 Per Share in Tax-EffectedSpecial Charges. EBITDA Was $221.1 Million, Up 12%; Adjusted EBITDA Was $226.0 Million, Up 6%. \"We were pleased to announce in early January 2025 the acquisition of Applied Energy Group  that was completed on December 31, 2024. AEG is a leading energy technology and advisory service","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/icf-reports-fourth-quarter-full-210500992.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/icf-reports-fourth-quarter-full-210500992.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["AEG","EC","LU1430594728.SGD","ICF","LU1585245621.USD","LU2065731478.USD","BK4588","BK4114","BK4162","LU1989763690.USD","BK4123","DG","BK4155","BK4504","BK4585","ICFI","BK4201","LU1989763427.SGD"],"gpt_icon":0},{"id":"2514438800","title":"Moody's Maintains Ecopetrol's Global Credit Rating at Ba1 with a Stable Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2514438800","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514438800?lang=en_us&edition=fundamental","pubTime":"2025-02-27 21:52","pubTimestamp":1740664320,"startTime":"0","endTime":"0","summary":"BOGOTA, Colombia, Feb. 27, 2025 /PRNewswire/ -- Ecopetrol S.A.   informs that, on February 24, 2025, Moody's reported the results of its periodic review of the Company's rating, maintaining its global credit rating at Ba1 with a stable outlook. Similarly, the individual rating remains at b1.Moody's noted that the global rating of 'Ba1' reflects the Company's status as the main producer of oil and gas in Colombia, with approximately 60% of the country's production, as well as its significant energy transmission business in Colombia and other Latin American countries, and a solid and stable cash flow in its subsidiaries Interconexión Eléctrica S.A. E.S.P. and Cenit SAS.The rating agency highlighted the increase in production and the reduction of the balance of the Fuel Price Stabilization Fund , which supports the Company's liquidity, and mentioned that Moody's expects that Ecopetrol's financial obligations will continue to be supported by access to global and Colombian capital markets, ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/moodys-maintains-ecopetrols-global-credit-135200444.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/moodys-maintains-ecopetrols-global-credit-135200444.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["EC","MCO"],"gpt_icon":0},{"id":"2514099448","title":"TG Therapeutics Announces Presentation of Data for BRIUMVI® in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum","url":"https://stock-news.laohu8.com/highlight/detail?id=2514099448","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514099448?lang=en_us&edition=fundamental","pubTime":"2025-02-27 20:30","pubTimestamp":1740659400,"startTime":"0","endTime":"0","summary":"NEW YORK, Feb.  27, 2025  (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the presentation of data from the ULTIMATE I & II Phase 3 trials and the ENHANCE Phase 3b trial eval","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/02/27/3033752/8790/en/TG-Therapeutics-Announces-Presentation-of-Data-for-BRIUMVI-in-Multiple-Sclerosis-at-the-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis-Annual-Forum.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0106831901.USD","BK4201","LU1668664300.SGD","LU1720051017.SGD","TGTX","BK4139","LU0912757837.SGD","BK4135","LU0006306889.USD","CNS","LU0795875086.SGD","LU0158827948.USD","EC","LU0267386448.USD","LU1162221912.USD","BK4179","BK4090","LU2271345857.HKD","IE00BKVL7J92.USD","LU1732800096.USD","LU2028103732.USD","LU0795875169.SGD","BK4581","LU0106261372.USD","PML","LU2023251221.USD","LU1548497426.USD","LU2089283258.USD","LU2111349929.HKD","LU1989772923.USD","LU2089284900.SGD","LU1720051108.HKD","LU2133065610.SGD","BK4516","TG","BK4585","LU0098860793.USD","BK4153","BK4534","LU1989772840.SGD","LU1732799900.SGD","LU0225283273.USD","LU2357305700.SGD","BK4127","LU0971096721.USD","FET","BK4504","LU1074936037.SGD","LU0158827781.USD","BK4588"],"gpt_icon":0},{"id":"2514550806","title":"Ligand Reports Fourth Quarter and Full Year 2024 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2514550806","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514550806?lang=en_us&edition=fundamental","pubTime":"2025-02-27 20:00","pubTimestamp":1740657600,"startTime":"0","endTime":"0","summary":"Robust financial performance driven by full year 2024 royalty revenue growth of 28% Reiterating 2025 financial guidance of $180-$200 million in revenues and adjusted earnings per diluted share1 of $6.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/02/27/3033694/0/en/Ligand-Reports-Fourth-Quarter-and-Full-Year-2024-Financial-Results.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4087","BK4588","MLM","BK4156","BK4011","EC","FSGS","SG9999001077.SGD","BK4201","BK4585","CHMP","LU2237438978.USD","LU0053666078.USD","BK4548"],"gpt_icon":0},{"id":"2514877680","title":"BeiGene Announces Fourth Quarter and Full Year 2024 Financial Results and Business Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2514877680","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514877680?lang=en_us&edition=fundamental","pubTime":"2025-02-27 19:00","pubTimestamp":1740654000,"startTime":"0","endTime":"0","summary":"Total global revenues of $1.1 billion and $3.8 billion for the fourth quarter and full year, increases of 78% and 55%, respectively; narrowed GAAP operating loss and achieved full-year positive non-GAAP operating income. Global BRUKINSA revenues of $828 million and $2.6 billion for the fourth quarter and full year, increases of 100% and 105%, respectively; progressed pivotal-stage programs for BCL2 inhibitor sonrotoclax and BTK CDAC BGB-16673. Advanced six and 13 New Molecular Entities  into the clinic in the fourth quarter and full year, respectively; anticipate multiple data readouts for innovative solid tumor programs in 1H 2025. Full year 2025 revenue guidance of $4.9 billion to $5.3 billion, reaffirm anticipated positive GAAP operating income and cash flow generation from operations in 2025","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/beigene-announces-fourth-quarter-full-110000380.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4109","BK4139","BK4585","LU0053666078.USD","BK4107","BK4201","LU2463526074.USD","ONC","EC","BK4588","L","ASH"],"gpt_icon":0},{"id":"2514389274","title":"Ecopetrol (EC) Stock Slides as Market Rises: Facts to Know Before You Trade","url":"https://stock-news.laohu8.com/highlight/detail?id=2514389274","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514389274?lang=en_us&edition=fundamental","pubTime":"2025-02-27 06:50","pubTimestamp":1740610211,"startTime":"0","endTime":"0","summary":"Ecopetrol  closed the latest trading day at $10.12, indicating a -1.36% change from the previous session's end. This change lagged the S&P 500's daily gain of 0.01%. On the other hand, the Dow registered a loss of 0.43%, and the technology-centric Nasdaq increased by 0.26%.The the stock of oil and natural gas exploration company has risen by 19.16% in the past month, leading the Oils-Energy sector's loss of 4.3% and the S&P 500's loss of 2.26%.The upcoming earnings release of Ecopetrol will be of great interest to investors. The company's earnings report is expected on March 4, 2025. It is anticipated that the company will report an EPS of $0.36, marking a 51.35% fall compared to the same quarter of the previous year. Simultaneously, our latest consensus estimate expects the revenue to be $7.99 billion, showing a 6.95% drop compared to the year-ago quarter.Furthermore, it would be beneficial for investors to monitor any recent shifts in analyst projections for Ecopetrol. Recent revisio","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/ecopetrol-ec-stock-slides-market-225011101.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["EC","BK4201"],"gpt_icon":0},{"id":"2514834684","title":"TG Therapeutics to Host Conference Call on Fourth Quarter and Full Year 2024 Financial Results and Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2514834684","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514834684?lang=en_us&edition=fundamental","pubTime":"2025-02-26 20:30","pubTimestamp":1740573000,"startTime":"0","endTime":"0","summary":"Conference call to be held Monday, March 3, 2025, at 8:30 AM ETNEW YORK, Feb.  26, 2025  (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced that a conference call will be held, ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/02/26/3032812/8790/en/TG-Therapeutics-to-Host-Conference-Call-on-Fourth-Quarter-and-Full-Year-2024-Financial-Results-and-Business-Update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TG","BK4153","BK4588","BK4218","BK4585","EC","BK4181","HST","TGTX","BK4090","BK4201","BK4139"],"gpt_icon":0},{"id":"2514839106","title":"Rhythm Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2514839106","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514839106?lang=en_us&edition=fundamental","pubTime":"2025-02-26 20:00","pubTimestamp":1740571200,"startTime":"0","endTime":"0","summary":"-- Fourth quarter 2024 net revenue from global sales of IMCIVREE  of $41.8 million --. -- On track to report topline data from global Phase 3 trial evaluating setmelanotide in acquired hypothalamic obesity in the second quarter of 2025 --. -- Completed enrollment in the Phase 2 trial of oral MC4R agonist bivamelagon in acquired hypothalamic obesity --. -- FDA approved expanded label for IMCIVREE to include children as young as 2 years old --. -- Raised approximately $75 million in gross proceeds under ATM equity offering program; Cash runway extended into 2027 --. BOSTON, Feb. 26, 2025  -- Rhythm Pharmaceuticals, Inc. , a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine diseases, today reported financial results and provided a business update for the fourth quarter and full year ended December 31, 2024.Today, Rhythm announced a strategic partnership agreement with Trispera Pharma Solutions in Turkey;","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/rhythm-pharmaceuticals-reports-fourth-quarter-120000027.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["EC","BK4588","PWS","BK4585","BK4201","BK4139","RYTM"],"gpt_icon":0},{"id":"2514086335","title":"Stocks to watch: Great Eastern, FCT, Yangzijiang Financial, PropNex, EC World Reit","url":"https://stock-news.laohu8.com/highlight/detail?id=2514086335","media":"businesstimes","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514086335?lang=en_us&edition=fundamental","pubTime":"2025-02-25 00:35","pubTimestamp":1740414941,"startTime":"0","endTime":"0","summary":"THE following companies saw new developments that may affect trading of their securities on Tuesday (Feb 25).\n","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"bustime_highlight","url":"https://www.businesstimes.com.sg/companies-markets/stocks-watch-great-eastern-fct-yangzijiang-financial-propnex-ec-world-reit","rn_cache_url":null,"customStyle":"","selectors":"body","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.businesstimes.com.sg/companies-markets/stocks-watch-great-eastern-fct-yangzijiang-financial-propnex-ec-world-reit","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"bustime_highlight","symbols":["SG9999003826.SGD","BK4201","LU0516422366.SGD","SG9999013478.USD","LU1242518931.SGD","EC","SG9999014492.USD","FCT","SG9999016042.SGD","BK6504","LU0516423174.USD","LU0164939612.USD","CFA.SI","LU0979878070.USD","LU0516422440.USD","SGXZ24219693.SGD","SG9999014484.SGD","LU0516423091.SGD","LU1242518857.USD","SG9999004360.SGD","BK6065","LU0516422952.EUR","EML","LU0082770016.USD","SGXZ43160589.SGD","SGXZ58947870.SGD","LU0620787316.HKD","SG9999000343.SGD","SG9999013460.SGD","LU0082770016.SGD","BK4161","SGXZ27511609.SGD","SG9999000475.SGD","SG9999013486.USD"],"gpt_icon":1},{"id":"2513718969","title":"Almirall 2024 Full-Year Results: Almirall Surpassed Guidance for 2024 - Entering an Era of Sustained Growth and Further Advancing Its Medical Dermatology Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2513718969","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513718969?lang=en_us&edition=fundamental","pubTime":"2025-02-24 14:00","pubTimestamp":1740376800,"startTime":"0","endTime":"0","summary":"Almirall’s net sales growth in 2024 was 10.2% YoY  with EBITDA growth of 10.6% YoY  – surpassing guidance for the year with all key growth drivers delivering double digit growth.Company revenue growth continues to be driven by the strong performance of the European Dermatology business , specifically biologics.Ebglyss achieved 34% growth in Q4 compared to Q3, delivering a total of 33.2 MM sales in 2024, mainly in Germany. The product is now available in 11 markets across Europe and continues to receive very positive feedback from dermatologists.Ilumetri continued its very strong growth trajectory with 25.5% sales increase YoY, delivering sales of 208.8 MM – based on continued market expansion and taking a higher share from competition.Strong performance of Almiralls broad dermatology portfolio: Wynzora grew 53.3% YoY , and Klisyri grew 17.8% YoY . Sustained solid growth of the medical dermatology portfolio overall: 17.8% .","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/almirall-2024-full-results-almirall-060000142.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4201","CAGR","BK4159","BK4007","LBTSF","ALMRY","EC"],"gpt_icon":0},{"id":"2513024107","title":"ECOPETROL S.A.: Call for General Shareholders' Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2513024107","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513024107?lang=en_us&edition=fundamental","pubTime":"2025-02-22 08:38","pubTimestamp":1740184680,"startTime":"0","endTime":"0","summary":"BOGOTA, Colombia, Feb. 21, 2025 /PRNewswire/ -- The Chief Executive Officer of Ecopetrol S.A.  hereby summons all Shareholders to theGeneral Shareholders' Meetingto be held on Friday,March 28,2025,starting at 9:00 a.m.,at the Centro Internacional de Negocios y Exposiciones ,located on Carrera 37 No.24 - 67 in Bogota,D.C.Opening of the General Shareholders' Meeting by the ChiefExecutive OfficerofEcopetrol. Appointment of the commission responsible for scrutiny and countingofthevotes. Presentation and consideration of the Board of Directors' reporton its performance, development, and compliance with the Corporate Governance Code. Presentation and consideration of the individual and consolidated audited financial statements as of December 31, 2024. Election of the Statutory Auditor for the 2025 – 2029 period and assignment of his remuneration. Election of Board Members for the 2025 - 2029 period. Presentation and approval of amendments to the Internal Regulations of the General Shareholde","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/ecopetrol-call-general-shareholders-meeting-003800615.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/ecopetrol-call-general-shareholders-meeting-003800615.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4201","EC"],"gpt_icon":0},{"id":"2513524100","title":"Ecopetrol publishes measures to guarantee the adequate representation of its Shareholders at the Ordinary General Shareholders' Meeting to be held on March 28, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2513524100","media":"PR Newswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513524100?lang=en_us&edition=fundamental","pubTime":"2025-02-22 08:34","pubTimestamp":1740184440,"startTime":"0","endTime":"0","summary":"BOGOTA, Colombia, Feb. 21, 2025 /PRNewswire/ -- Ecopetrol S.A.   informs that, to comply with the provisions of Part III Title I Chapter VI of the Basic Legal Circular issued by the Financial Superintendence of Colombia , the Board of Directors of Ecopetrol approved the implementation of the measures described below which are aimed at guaranteeing the adequate representation of shareholders at the Ordinary General Shareholder's Meeting to be held on March 28, 2025. The Board instructed the Company's management to:. Inform shareholders of their right to be represented through the appointment of a proxy and indicate the legal requirements of the proxies to be granted for such purpose.These measures were adopted by the members of the Board of Directors of Ecopetrol in a meeting held on February 21, 2025 and are expected to be implemented prior to the Ordinary General Shareholders Meeting.This release contains statements that may be considered forward-looking statements","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/ecopetrol-publishes-measures-guarantee-adequate-003400179.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/ecopetrol-publishes-measures-guarantee-adequate-003400179.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4201","EC"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":4,"totalSize":200}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/EC\",params:#limit:5,,,undefined,":[{"date":"2025-06-26","symbol":"EC","amount":0.5202,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-26","defaultRemindTime":1750944600000,"name":"哥伦比亚国家石油","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-07","payableDate":"2025-06-26","currency":"USD","dateTimestamp":1750910400000,"payDate":"2025-07-07"},{"date":"2025-04-03","symbol":"EC","amount":0.5202,"announcedDate":"2025-03-13","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-04-03","defaultRemindTime":1743687000000,"name":"哥伦比亚国家石油","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-11","payableDate":"2025-04-03","currency":"USD","dateTimestamp":1743652800000,"payDate":"2025-04-11"},{"market":"US","date":"2025-03-04","symbol":"EC","fiscalQuarterEnding":"2024/12","expectedEps":0.36,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1741064400000,"reportTimeType":"post","actualEps":0.74},{"market":"US","date":"2024-11-13","symbol":"EC","fiscalQuarterEnding":"2024/09","expectedEps":0.46,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731474000000,"reportTimeType":"post","actualEps":0.61},{"market":"US","date":"2024-08-13","symbol":"EC","fiscalQuarterEnding":"2024/06","expectedEps":0.57,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723521600000,"reportTimeType":"post","actualEps":0.45}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"EC\",market:\"US\",,,undefined,":[{"executeDate":"2015-06-17","recordDate":"2015-06-19","paymentDate":"2015-06-30","value":1.0397119,"currency":"USD"},{"executeDate":"2017-04-25","recordDate":"2017-04-27","paymentDate":"2017-05-08","value":0.160581,"currency":"USD"},{"executeDate":"2018-04-17","recordDate":"2018-04-18","paymentDate":"2018-04-27","value":0.605505,"currency":"USD"},{"executeDate":"2019-04-23","recordDate":"2019-04-24","paymentDate":"2019-05-03","value":1.0849538,"currency":"USD"},{"executeDate":"2019-12-26","recordDate":"2019-12-27","paymentDate":"2020-01-02","value":0.4861737,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"EC\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.0909,"buy":0,"hold":0.5455,"sell":0.2727,"strongSell":0.0909,"meanLabel":"HOLD","meanPercent":0.5455,"analysts":11,"updateTime":1739851200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/EC\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"EC","date":"2025-04-03","current":5.726442,"percent":0.534146,"low":2.588919,"twenty":3.863076,"median":5.451025,"eighty":12.825744,"high":64.266012,"avg":9.872573,"sd":11.437146,"marketCap":20654669602.28},"quantilePoints":[{"date":"2020-04-09","current":7.060195,"twenty":-8.145361,"median":10.488174,"eighty":13.847901,"marketCap":25102286700.23},{"date":"2020-04-17","current":5.833636,"twenty":-8.145361,"median":10.484881,"eighty":13.847901,"marketCap":20130951753.92},{"date":"2020-04-24","current":5.713971,"twenty":-8.115955,"median":10.451604,"eighty":13.826153,"marketCap":19439795746.79},{"date":"2020-05-01","current":6.252461,"twenty":-8.115955,"median":10.432105,"eighty":13.778662,"marketCap":21690070900.86},{"date":"2020-05-08","current":6.102881,"twenty":-8.115955,"median":10.415218,"eighty":13.778662,"marketCap":21658246531.61},{"date":"2020-05-15","current":7.128331,"twenty":-8.115955,"median":10.390367,"eighty":13.778662,"marketCap":20193195773.75},{"date":"2020-05-22","current":7.276069,"twenty":-8.115955,"median":10.372727,"eighty":13.733732,"marketCap":21421174870.89},{"date":"2020-05-29","current":7.349937,"twenty":-8.115955,"median":10.362824,"eighty":13.714284,"marketCap":22056885495.23},{"date":"2020-06-05","current":8.661107,"twenty":-8.115955,"median":10.344145,"eighty":13.709422,"marketCap":27085411834.39},{"date":"2020-06-12","current":7.848551,"twenty":-8.115955,"median":10.319805,"eighty":13.699296,"marketCap":23200471645.31},{"date":"2020-06-19","current":7.903953,"twenty":-8.092431,"median":10.300132,"eighty":13.688426,"marketCap":23609994267.63},{"date":"2020-06-26","current":7.645412,"twenty":-8.08655,"median":10.287946,"eighty":13.686342,"marketCap":22623417242.58},{"date":"2020-07-02","current":7.682347,"twenty":-8.08655,"median":10.273776,"eighty":13.686342,"marketCap":23374528521.7},{"date":"2020-07-10","current":7.682347,"twenty":-8.08655,"median":10.231601,"eighty":13.672495,"marketCap":23632243210.7},{"date":"2020-07-17","current":8.199428,"twenty":-8.08655,"median":10.199864,"eighty":13.663263,"marketCap":25086314025.12},{"date":"2020-07-24","current":8.199428,"twenty":-8.068906,"median":10.178679,"eighty":13.650092,"marketCap":24734192014.9},{"date":"2020-07-31","current":7.682347,"twenty":-8.057144,"median":10.111782,"eighty":13.640634,"marketCap":22930803559.42},{"date":"2020-08-07","current":11.632318,"twenty":-8.057144,"median":10.172576,"eighty":13.640183,"marketCap":23832899932.5},{"date":"2020-08-14","current":11.793133,"twenty":-8.057144,"median":10.192421,"eighty":13.629769,"marketCap":23903159981.5},{"date":"2020-08-21","current":11.685923,"twenty":-8.057144,"median":10.231601,"eighty":13.619393,"marketCap":23443635095.52},{"date":"2020-08-28","current":11.65912,"twenty":-8.057144,"median":10.270329,"eighty":13.617103,"marketCap":23779198827.58},{"date":"2020-09-04","current":11.498305,"twenty":-8.057144,"median":10.284523,"eighty":13.609447,"marketCap":23776806974.38},{"date":"2020-09-11","current":10.855043,"twenty":-8.057144,"median":10.291369,"eighty":13.600215,"marketCap":22417626544.05},{"date":"2020-09-18","current":11.337489,"twenty":-8.057144,"median":10.314383,"eighty":13.584791,"marketCap":23327291308.61},{"date":"2020-09-25","current":10.292189,"twenty":-8.057144,"median":10.319805,"eighty":13.561711,"marketCap":20378443894.99},{"date":"2020-10-02","current":10.238584,"twenty":-8.057144,"median":10.314383,"eighty":13.538631,"marketCap":20154725229.8},{"date":"2020-10-09","current":10.388678,"twenty":-8.057144,"median":10.308961,"eighty":13.478624,"marketCap":20836271816.86},{"date":"2020-10-16","current":10.077768,"twenty":-8.057144,"median":10.29616,"eighty":13.39092,"marketCap":20097076675.56},{"date":"2020-10-23","current":9.970558,"twenty":-8.057144,"median":10.291369,"eighty":13.344761,"marketCap":20240056139.58},{"date":"2020-10-30","current":13.354362,"twenty":-8.045382,"median":10.291779,"eighty":13.339443,"marketCap":19098996340.43},{"date":"2020-11-06","current":13.66753,"twenty":-8.027739,"median":10.300132,"eighty":13.478624,"marketCap":20189365488.02},{"date":"2020-11-13","current":14.912744,"twenty":-8.027739,"median":10.319805,"eighty":13.590618,"marketCap":22610846979.57},{"date":"2020-11-20","current":16.053569,"twenty":-8.027739,"median":10.344145,"eighty":13.620537,"marketCap":24261858653.1},{"date":"2020-11-27","current":16.19524,"twenty":-8.027739,"median":10.361737,"eighty":13.641085,"marketCap":24731503978.59},{"date":"2020-12-04","current":16.500951,"twenty":-8.027739,"median":10.372727,"eighty":13.68258,"marketCap":26223772364.1},{"date":"2020-12-11","current":17.224219,"twenty":-8.027739,"median":10.388678,"eighty":13.70689,"marketCap":27667442900.73},{"date":"2020-12-18","current":17.343521,"twenty":-8.027739,"median":10.399188,"eighty":13.778662,"marketCap":27962526123.89},{"date":"2020-12-24","current":17.052723,"twenty":-8.027739,"median":10.415218,"eighty":13.826153,"marketCap":26881415841.75},{"date":"2020-12-31","current":16.739555,"twenty":-8.027739,"median":10.428877,"eighty":13.864693,"marketCap":26994291439.99},{"date":"2021-01-08","current":17.887837,"twenty":-8.027739,"median":10.443632,"eighty":13.884097,"marketCap":28336383384.46},{"date":"2021-01-15","current":18.04442,"twenty":-8.004214,"median":10.45629,"eighty":13.94086,"marketCap":28718079297.45},{"date":"2021-01-22","current":17.5523,"twenty":-7.998333,"median":10.472905,"eighty":13.9633,"marketCap":27428996316},{"date":"2021-01-29","current":15.136435,"twenty":-7.998333,"median":10.484881,"eighty":13.996226,"marketCap":23416813550.86},{"date":"2021-02-05","current":16.068482,"twenty":-7.998333,"median":10.499343,"eighty":14.123084,"marketCap":25042104133.89},{"date":"2021-02-12","current":16.0312,"twenty":-7.998333,"median":10.512522,"eighty":14.180251,"marketCap":25204109478.1},{"date":"2021-02-19","current":16.143045,"twenty":-7.986571,"median":10.513852,"eighty":14.217179,"marketCap":25046465773.01},{"date":"2021-02-26","current":58.305857,"twenty":-7.968927,"median":10.548119,"eighty":14.277186,"marketCap":25507337685.76},{"date":"2021-03-05","current":62.192915,"twenty":-7.968927,"median":10.549134,"eighty":14.309498,"marketCap":27185340438.03},{"date":"2021-03-12","current":61.622813,"twenty":-7.968927,"median":10.55525,"eighty":14.383353,"marketCap":27404215357.16},{"date":"2021-03-19","current":61.415503,"twenty":-7.968927,"median":10.560215,"eighty":14.424897,"marketCap":27381860856.27},{"date":"2021-03-26","current":60.923143,"twenty":-7.968927,"median":10.566774,"eighty":14.471057,"marketCap":26275612062.35},{"date":"2021-04-01","current":61.311848,"twenty":-7.968927,"median":10.569887,"eighty":14.506881,"marketCap":26583440261.39},{"date":"2021-04-09","current":58.564995,"twenty":-7.963046,"median":10.584415,"eighty":14.560475,"marketCap":25527094664.96},{"date":"2021-04-16","current":59.627457,"twenty":-7.939522,"median":10.587425,"eighty":14.602488,"marketCap":26281880793.85},{"date":"2021-04-23","current":57.735756,"twenty":-7.939522,"median":10.608026,"eighty":14.657491,"marketCap":25100144058.23},{"date":"2021-04-30","current":57.269309,"twenty":-7.939522,"median":10.61798,"eighty":14.744064,"marketCap":24302726735.73},{"date":"2021-05-07","current":20.722698,"twenty":-7.939522,"median":10.625618,"eighty":14.842782,"marketCap":25005315360.88},{"date":"2021-05-14","current":21.619353,"twenty":-7.933641,"median":10.625618,"eighty":15.002221,"marketCap":26643921768.12},{"date":"2021-05-21","current":20.695527,"twenty":-7.904235,"median":10.640622,"eighty":15.167685,"marketCap":25157084391.01},{"date":"2021-05-28","current":20.025299,"twenty":-7.88071,"median":10.65789,"eighty":15.365348,"marketCap":24472773564.38},{"date":"2021-06-04","current":21.329525,"twenty":-7.88071,"median":10.669598,"eighty":15.402274,"marketCap":26866573068.16},{"date":"2021-06-11","current":21.655582,"twenty":-7.88071,"median":10.685426,"eighty":15.557539,"marketCap":27175480153.64},{"date":"2021-06-18","current":21.709924,"twenty":-7.88071,"median":10.704782,"eighty":15.583818,"marketCap":26245397627.8},{"date":"2021-06-25","current":25.088231,"twenty":-7.88071,"median":10.720006,"eighty":15.743857,"marketCap":30460069078.47},{"date":"2021-07-02","current":25.821858,"twenty":-7.851305,"median":10.727521,"eighty":15.919354,"marketCap":31007458421.16},{"date":"2021-07-09","current":25.006717,"twenty":-7.804255,"median":10.758908,"eighty":15.993918,"marketCap":29565641596.76},{"date":"2021-07-16","current":23.186235,"twenty":-7.792493,"median":10.78369,"eighty":16.056552,"marketCap":27597991192.03},{"date":"2021-07-23","current":23.104721,"twenty":1.744237,"median":10.795303,"eighty":16.096961,"marketCap":27080627944.38},{"date":"2021-07-30","current":23.847405,"twenty":4.224151,"median":10.801539,"eighty":16.246916,"marketCap":28048152007.56},{"date":"2021-08-06","current":12.710961,"twenty":4.403647,"median":10.812794,"eighty":16.246916,"marketCap":26445510448.34},{"date":"2021-08-13","current":12.905593,"twenty":4.442538,"median":10.823748,"eighty":16.240705,"marketCap":27744434941.12},{"date":"2021-08-20","current":12.656065,"twenty":4.657934,"median":10.823748,"eighty":16.204333,"marketCap":26967345402.64},{"date":"2021-08-27","current":13.274894,"twenty":4.807514,"median":10.828241,"eighty":16.153484,"marketCap":28519011180.03},{"date":"2021-09-03","current":13.15013,"twenty":5.094709,"median":10.857136,"eighty":16.096961,"marketCap":28507430734.94},{"date":"2021-09-10","current":12.740904,"twenty":5.313096,"median":10.873763,"eighty":16.08544,"marketCap":27364682362.77},{"date":"2021-09-17","current":12.805782,"twenty":5.45071,"median":10.889499,"eighty":16.079739,"marketCap":27601161170.58},{"date":"2021-09-24","current":12.725933,"twenty":5.492593,"median":10.924728,"eighty":16.071464,"marketCap":27244457816.11},{"date":"2021-10-01","current":13.818866,"twenty":5.504559,"median":10.92749,"eighty":16.059534,"marketCap":30101294872.59},{"date":"2021-10-08","current":14.512554,"twenty":5.540458,"median":10.942084,"eighty":16.040148,"marketCap":31766032985.79},{"date":"2021-10-15","current":14.772063,"twenty":5.636189,"median":10.962071,"eighty":16.008831,"marketCap":32297167497.92},{"date":"2021-10-22","current":14.422724,"twenty":5.69303,"median":10.9698,"eighty":15.993918,"marketCap":31388448015.98},{"date":"2021-10-29","current":14.208129,"twenty":5.707988,"median":10.982384,"eighty":15.993918,"marketCap":30938584888.05},{"date":"2021-11-05","current":14.357846,"twenty":5.731921,"median":11.005297,"eighty":15.971549,"marketCap":30508260850.86},{"date":"2021-11-12","current":10.821451,"twenty":5.779787,"median":10.996652,"eighty":15.934267,"marketCap":30028393272.71},{"date":"2021-11-19","current":10.078429,"twenty":5.80372,"median":10.978125,"eighty":15.919354,"marketCap":27735497042.93},{"date":"2021-11-26","current":9.663099,"twenty":5.815686,"median":10.9698,"eighty":15.901459,"marketCap":25946683687.22},{"date":"2021-12-03","current":10.139395,"twenty":5.833636,"median":10.962253,"eighty":15.859703,"marketCap":27663402839.39},{"date":"2021-12-10","current":10.314672,"twenty":5.833636,"median":10.946258,"eighty":15.825404,"marketCap":28555311336.09},{"date":"2021-12-17","current":10.078429,"twenty":5.845602,"median":10.937911,"eighty":15.782048,"marketCap":27314059035.32},{"date":"2021-12-23","current":10.097481,"twenty":5.872527,"median":10.92749,"eighty":15.71334,"marketCap":27258209523.55},{"date":"2021-12-31","current":10.249896,"twenty":5.911418,"median":10.917433,"eighty":15.590738,"marketCap":27187431472.42},{"date":"2022-01-07","current":10.101291,"twenty":5.926376,"median":10.889499,"eighty":15.588592,"marketCap":26932288402.65},{"date":"2022-01-14","current":10.672847,"twenty":5.941334,"median":10.873763,"eighty":15.587637,"marketCap":28758892730.03},{"date":"2022-01-21","current":10.863365,"twenty":5.9533,"median":10.875619,"eighty":15.583818,"marketCap":29601943576.06},{"date":"2022-01-28","current":10.996728,"twenty":6.102881,"median":10.889499,"eighty":15.583818,"marketCap":29787077559.89},{"date":"2022-02-04","current":11.053884,"twenty":6.177671,"median":10.911516,"eighty":15.557539,"marketCap":30226428284.35},{"date":"2022-02-11","current":11.32442,"twenty":6.204595,"median":10.924728,"eighty":15.557539,"marketCap":31213777266},{"date":"2022-02-18","current":11.419679,"twenty":6.264427,"median":10.942084,"eighty":15.557539,"marketCap":31437797276.81},{"date":"2022-02-25","current":11.674974,"twenty":6.719152,"median":10.966026,"eighty":15.557539,"marketCap":32235185643.05},{"date":"2022-03-04","current":8.775545,"twenty":7.060195,"median":10.9698,"eighty":15.557539,"marketCap":35993542030.87},{"date":"2022-03-11","current":8.93319,"twenty":7.246521,"median":10.9698,"eighty":15.557539,"marketCap":36596969016.47},{"date":"2022-03-18","current":8.591626,"twenty":7.364711,"median":10.9698,"eighty":15.557539,"marketCap":35253970222.95},{"date":"2022-03-25","current":9.432397,"twenty":7.512449,"median":10.9698,"eighty":15.557539,"marketCap":38980889412.18},{"date":"2022-04-01","current":9.274753,"twenty":7.608478,"median":10.9698,"eighty":15.557539,"marketCap":38450231073.35},{"date":"2022-04-08","current":9.379849,"twenty":7.682347,"median":10.9698,"eighty":15.557539,"marketCap":38840654118.15},{"date":"2022-04-14","current":8.79131,"twenty":7.734055,"median":10.9698,"eighty":15.557539,"marketCap":36814680340.58},{"date":"2022-04-22","current":8.814956,"twenty":7.848551,"median":10.9698,"eighty":15.557539,"marketCap":36083314330.36},{"date":"2022-04-29","current":8.423472,"twenty":7.937194,"median":10.9698,"eighty":15.557539,"marketCap":33232522355.71},{"date":"2022-05-06","current":8.612646,"twenty":8.036916,"median":10.9698,"eighty":15.557539,"marketCap":33355736677.76},{"date":"2022-05-13","current":6.665183,"twenty":8.103632,"median":10.9698,"eighty":15.557539,"marketCap":31053756069.43},{"date":"2022-05-20","current":6.100082,"twenty":8.103632,"median":10.9698,"eighty":15.557539,"marketCap":29215441427.83},{"date":"2022-05-27","current":6.443869,"twenty":8.103632,"median":10.9698,"eighty":15.557539,"marketCap":31633906458.52},{"date":"2022-06-03","current":7.09062,"twenty":8.103632,"median":10.9698,"eighty":15.557539,"marketCap":36015579040.45},{"date":"2022-06-10","current":6.768319,"twenty":8.103632,"median":10.9698,"eighty":15.557539,"marketCap":33175611750.38},{"date":"2022-06-17","current":5.930337,"twenty":8.103632,"median":10.9698,"eighty":15.557539,"marketCap":29053271209.52},{"date":"2022-06-24","current":4.596011,"twenty":8.121847,"median":10.9698,"eighty":15.557539,"marketCap":21309510065.4},{"date":"2022-07-01","current":5.049381,"twenty":8.121847,"median":10.9698,"eighty":15.557539,"marketCap":23031543041.38},{"date":"2022-07-08","current":4.941947,"twenty":8.121847,"median":10.9698,"eighty":15.557539,"marketCap":21588001138.43},{"date":"2022-07-15","current":4.507915,"twenty":8.121847,"median":10.9698,"eighty":15.557539,"marketCap":19716315930.61},{"date":"2022-07-22","current":4.426266,"twenty":8.121847,"median":10.9698,"eighty":15.557539,"marketCap":19171225427.54},{"date":"2022-07-29","current":4.898974,"twenty":8.121847,"median":10.9698,"eighty":15.557539,"marketCap":21883856364.26},{"date":"2022-08-05","current":3.574458,"twenty":8.121847,"median":10.9698,"eighty":15.557539,"marketCap":21338876009.71},{"date":"2022-08-12","current":3.730145,"twenty":8.121847,"median":10.9698,"eighty":15.557539,"marketCap":23041049912.2},{"date":"2022-08-19","current":3.601465,"twenty":8.121847,"median":10.9698,"eighty":15.557539,"marketCap":21140719616.75},{"date":"2022-08-26","current":3.841351,"twenty":8.121847,"median":10.9698,"eighty":15.557539,"marketCap":22629951917.79},{"date":"2022-09-02","current":3.650713,"twenty":8.121847,"median":10.9698,"eighty":15.557539,"marketCap":21012334466.97},{"date":"2022-09-09","current":3.704727,"twenty":8.121847,"median":10.9698,"eighty":15.557539,"marketCap":21967588896.88},{"date":"2022-09-16","current":3.65389,"twenty":8.121847,"median":10.9698,"eighty":15.557539,"marketCap":21341487133.73},{"date":"2022-09-23","current":3.23131,"twenty":8.121847,"median":10.9698,"eighty":15.557539,"marketCap":18854575930.98},{"date":"2022-09-30","current":3.294856,"twenty":8.121847,"median":10.9698,"eighty":15.557539,"marketCap":18534639915.46},{"date":"2022-10-07","current":3.717436,"twenty":8.121847,"median":10.9698,"eighty":15.557539,"marketCap":20860105711.81},{"date":"2022-10-14","current":3.431479,"twenty":8.121847,"median":10.9698,"eighty":15.557539,"marketCap":19210084039.28},{"date":"2022-10-21","current":3.738088,"twenty":8.121847,"median":10.9698,"eighty":15.557539,"marketCap":19779927748.93},{"date":"2022-10-28","current":3.828641,"twenty":8.121847,"median":10.9698,"eighty":15.557539,"marketCap":20554935737.41},{"date":"2022-11-04","current":4.035166,"twenty":8.121847,"median":10.9698,"eighty":15.557539,"marketCap":20491789367.72},{"date":"2022-11-11","current":3.24681,"twenty":8.121847,"median":10.9698,"eighty":15.557539,"marketCap":20458414210.6},{"date":"2022-11-18","current":3.361163,"twenty":8.121847,"median":10.9698,"eighty":15.557539,"marketCap":20337590990.79},{"date":"2022-11-25","current":3.344827,"twenty":8.121847,"median":10.9698,"eighty":15.557539,"marketCap":20723664325.37},{"date":"2022-12-02","current":3.127012,"twenty":8.121847,"median":10.9698,"eighty":15.557539,"marketCap":19844314857.84},{"date":"2022-12-09","current":2.988155,"twenty":8.121847,"median":10.9698,"eighty":15.557539,"marketCap":18750367698.78},{"date":"2022-12-16","current":2.903751,"twenty":8.121847,"median":10.9698,"eighty":15.557539,"marketCap":18284182498.81},{"date":"2022-12-23","current":3.131096,"twenty":8.121847,"median":10.9698,"eighty":15.557539,"marketCap":19947772061.04},{"date":"2022-12-30","current":3.294457,"twenty":8.121847,"median":10.9698,"eighty":15.557539,"marketCap":20529504239.87},{"date":"2023-01-06","current":3.602122,"twenty":7.977821,"median":10.962071,"eighty":15.448048,"marketCap":22389902276.09},{"date":"2023-01-13","current":3.694693,"twenty":7.915033,"median":10.92749,"eighty":15.353601,"marketCap":23782172411.38},{"date":"2023-01-20","current":3.74234,"twenty":7.848551,"median":10.9129,"eighty":15.15206,"marketCap":24396148087.2},{"date":"2023-01-27","current":3.549029,"twenty":7.730361,"median":10.871907,"eighty":14.912744,"marketCap":23576646443.82},{"date":"2023-02-03","current":3.453735,"twenty":7.67496,"median":10.855043,"eighty":14.784787,"marketCap":22203715289.17},{"date":"2023-02-10","current":3.578979,"twenty":7.608478,"median":10.823748,"eighty":14.726178,"marketCap":22573097153.72},{"date":"2023-02-17","current":3.452374,"twenty":7.460741,"median":10.819131,"eighty":14.657544,"marketCap":21286938129.56},{"date":"2023-02-24","current":3.566727,"twenty":7.361018,"median":10.801539,"eighty":14.626454,"marketCap":22170808225.69},{"date":"2023-03-03","current":3.545128,"twenty":7.216974,"median":10.78369,"eighty":14.586838,"marketCap":23427703717.77},{"date":"2023-03-10","current":3.317459,"twenty":7.088595,"median":10.7295,"eighty":14.524941,"marketCap":22187614317.96},{"date":"2023-03-17","current":3.122315,"twenty":7.0094,"median":10.713578,"eighty":14.500509,"marketCap":20406573454.93},{"date":"2023-03-24","current":2.988315,"twenty":6.781898,"median":10.678394,"eighty":14.458692,"marketCap":19971462825.74},{"date":"2023-03-31","current":3.187363,"twenty":6.671286,"median":10.65789,"eighty":14.423159,"marketCap":21760504177.85},{"date":"2023-04-06","current":3.30445,"twenty":6.650793,"median":10.635059,"eighty":14.418662,"marketCap":22872624729},{"date":"2023-04-14","current":3.334372,"twenty":6.418945,"median":10.625618,"eighty":14.355658,"marketCap":23842101468.43},{"date":"2023-04-21","current":3.27843,"twenty":6.252461,"median":10.590434,"eighty":14.307221,"marketCap":22859238559.53},{"date":"2023-04-28","current":2.84651,"twenty":6.208833,"median":10.584415,"eighty":14.251173,"marketCap":19349032795.29},{"date":"2023-05-05","current":2.588919,"twenty":6.139878,"median":10.566774,"eighty":14.215464,"marketCap":17727705001.21},{"date":"2023-05-12","current":2.799899,"twenty":5.947317,"median":10.55525,"eighty":14.180251,"marketCap":18718310549.59},{"date":"2023-05-19","current":2.830711,"twenty":5.851586,"median":10.547103,"eighty":14.107762,"marketCap":19231782153.84},{"date":"2023-05-26","current":2.794541,"twenty":5.779787,"median":10.513852,"eighty":14.036335,"marketCap":19186073980.7},{"date":"2023-06-02","current":2.765068,"twenty":5.636189,"median":10.502473,"eighty":13.996226,"marketCap":19252463212.38},{"date":"2023-06-09","current":2.908412,"twenty":5.338256,"median":10.484881,"eighty":13.941499,"marketCap":21397594307.35},{"date":"2023-06-16","current":2.884224,"twenty":4.96902,"median":10.443632,"eighty":13.927233,"marketCap":21241570166.18},{"date":"2023-06-23","current":2.877526,"twenty":4.924758,"median":10.424038,"eighty":13.931562,"marketCap":21499710361.53},{"date":"2023-06-30","current":2.884224,"twenty":4.886941,"median":10.390367,"eighty":13.91118,"marketCap":21130530306.86},{"date":"2023-07-07","current":2.853413,"twenty":4.835802,"median":10.372727,"eighty":13.879481,"marketCap":20797568199.88},{"date":"2023-07-14","current":2.995414,"twenty":4.714842,"median":10.361737,"eighty":13.869409,"marketCap":22415987059.75},{"date":"2023-07-21","current":2.921734,"twenty":4.596011,"median":10.322954,"eighty":13.870981,"marketCap":22516260606.85},{"date":"2023-07-28","current":2.945847,"twenty":4.507915,"median":10.29616,"eighty":13.863121,"marketCap":23012958238.52},{"date":"2023-08-04","current":3.121339,"twenty":4.248084,"median":10.286261,"eighty":13.696764,"marketCap":23184235668.09},{"date":"2023-08-11","current":3.839397,"twenty":4.000076,"median":10.267916,"eighty":13.604343,"marketCap":23607572072.62},{"date":"2023-08-18","current":3.885026,"twenty":3.90194,"median":10.240429,"eighty":13.50446,"marketCap":23091698704.87},{"date":"2023-08-25","current":3.896866,"twenty":3.896866,"median":10.224768,"eighty":13.50446,"marketCap":23283897302.7},{"date":"2023-09-01","current":3.986507,"twenty":3.896866,"median":10.181829,"eighty":13.50446,"marketCap":23647467030.48},{"date":"2023-09-08","current":4.033865,"twenty":3.896866,"median":10.143425,"eighty":13.50446,"marketCap":24250288549.3},{"date":"2023-09-15","current":4.15395,"twenty":3.896866,"median":10.123411,"eighty":13.354362,"marketCap":25668539731.74},{"date":"2023-09-22","current":4.174247,"twenty":3.896866,"median":10.099573,"eighty":13.274894,"marketCap":25723339627.09},{"date":"2023-09-29","current":3.945915,"twenty":3.896866,"median":10.078098,"eighty":13.15013,"marketCap":23472544770.05},{"date":"2023-10-06","current":3.925618,"twenty":3.896866,"median":10.071608,"eighty":13.050319,"marketCap":21839950653.49},{"date":"2023-10-12","current":4.240209,"twenty":3.896866,"median":10.039952,"eighty":12.940527,"marketCap":24300899049.42},{"date":"2023-10-20","current":4.42964,"twenty":3.89593,"median":9.98317,"eighty":12.884329,"marketCap":25310163915.08},{"date":"2023-10-27","current":4.186086,"twenty":3.893123,"median":9.960618,"eighty":12.82556,"marketCap":24462456576.38},{"date":"2023-11-03","current":4.194543,"twenty":3.893123,"median":9.927672,"eighty":12.803786,"marketCap":25266844123.99},{"date":"2023-11-10","current":4.85945,"twenty":3.893123,"median":9.909277,"eighty":12.803786,"marketCap":23963749044.29},{"date":"2023-11-17","current":4.952503,"twenty":3.893123,"median":9.902932,"eighty":12.803786,"marketCap":24118759651.85},{"date":"2023-11-24","current":5.169817,"twenty":3.893123,"median":9.891721,"eighty":12.803786,"marketCap":25265887504.92},{"date":"2023-12-01","current":5.211175,"twenty":3.893123,"median":9.879822,"eighty":12.803786,"marketCap":25611546029.96},{"date":"2023-12-08","current":5.097439,"twenty":3.894059,"median":9.834565,"eighty":12.801789,"marketCap":25297686803.83},{"date":"2023-12-15","current":5.283553,"twenty":3.894059,"median":9.834565,"eighty":12.801789,"marketCap":26543991442.74},{"date":"2023-12-22","current":4.869967,"twenty":3.894059,"median":9.834565,"eighty":12.801789,"marketCap":24577966848.99},{"date":"2023-12-29","current":4.838949,"twenty":3.893123,"median":9.836153,"eighty":12.803786,"marketCap":25178756823.67},{"date":"2024-01-05","current":4.973364,"twenty":3.892187,"median":9.837742,"eighty":12.805782,"marketCap":25160462757.48},{"date":"2024-01-12","current":4.869967,"twenty":3.892187,"median":9.837742,"eighty":12.805782,"marketCap":24641765108.78},{"date":"2024-01-19","current":4.756231,"twenty":3.892187,"median":9.844654,"eighty":12.807778,"marketCap":24078522670.15},{"date":"2024-01-26","current":4.869967,"twenty":3.892187,"median":9.837742,"eighty":12.805782,"marketCap":24572977032.09},{"date":"2024-02-02","current":4.849288,"twenty":3.892187,"median":9.837742,"eighty":12.805782,"marketCap":24830968078.3},{"date":"2024-02-09","current":4.838949,"twenty":3.892187,"median":9.837742,"eighty":12.805782,"marketCap":24362672332.27},{"date":"2024-02-16","current":4.745892,"twenty":3.892187,"median":9.837742,"eighty":12.805782,"marketCap":24147298816.1},{"date":"2024-02-23","current":4.838949,"twenty":3.892187,"median":9.834565,"eighty":12.805782,"marketCap":24431341401.84},{"date":"2024-03-01","current":4.939525,"twenty":3.893123,"median":9.737218,"eighty":12.803786,"marketCap":23952488130.27},{"date":"2024-03-08","current":4.508126,"twenty":3.893123,"median":9.70238,"eighty":12.803786,"marketCap":21947666113.83},{"date":"2024-03-15","current":4.572814,"twenty":3.893123,"median":9.667099,"eighty":12.803786,"marketCap":22370689783.86},{"date":"2024-03-22","current":4.583599,"twenty":3.893123,"median":9.548009,"eighty":12.778323,"marketCap":22474207427.59},{"date":"2024-03-28","current":4.475749,"twenty":3.893123,"median":9.466237,"eighty":12.778323,"marketCap":22089724123.39},{"date":"2024-04-05","current":5.004211,"twenty":3.892187,"median":9.402489,"eighty":12.787678,"marketCap":25269737391.93},{"date":"2024-04-12","current":4.874792,"twenty":3.892187,"median":9.295772,"eighty":12.787678,"marketCap":24296961694.18},{"date":"2024-04-19","current":4.799298,"twenty":3.892187,"median":9.274753,"eighty":12.787678,"marketCap":23301659582.09},{"date":"2024-04-26","current":4.971857,"twenty":3.893123,"median":9.175126,"eighty":12.778323,"marketCap":23960050881.17},{"date":"2024-05-03","current":4.864007,"twenty":3.893123,"median":8.95412,"eighty":12.778323,"marketCap":23752567318.04},{"date":"2024-05-10","current":5.383345,"twenty":3.893123,"median":8.867182,"eighty":12.778323,"marketCap":24064602087.79},{"date":"2024-05-17","current":5.430568,"twenty":3.893123,"median":8.795251,"eighty":12.778323,"marketCap":24652224339.04},{"date":"2024-05-24","current":5.418762,"twenty":3.893123,"median":8.740075,"eighty":12.778323,"marketCap":24601197777.08},{"date":"2024-05-31","current":5.548903,"twenty":3.893123,"median":8.682856,"eighty":12.778323,"marketCap":24948806455.5},{"date":"2024-06-07","current":5.584322,"twenty":3.893123,"median":8.59294,"eighty":12.778323,"marketCap":24693614094.28},{"date":"2024-06-14","current":5.678771,"twenty":3.892187,"median":8.439501,"eighty":12.787678,"marketCap":23998459101.92},{"date":"2024-06-21","current":5.501679,"twenty":3.892187,"median":8.381434,"eighty":12.789302,"marketCap":22878611698.83},{"date":"2024-06-28","current":5.489873,"twenty":3.892187,"median":8.310231,"eighty":12.794176,"marketCap":22954501069.55},{"date":"2024-07-05","current":5.383617,"twenty":3.892187,"median":8.217895,"eighty":12.794176,"marketCap":22901200413.63},{"date":"2024-07-12","current":5.289168,"twenty":3.892187,"median":8.13183,"eighty":12.794176,"marketCap":23204604596.91},{"date":"2024-07-15","current":5.171106,"twenty":3.892187,"median":8.107092,"eighty":12.794176,"marketCap":22824658784.59},{"date":"2024-08-02","current":5.005819,"twenty":3.876246,"median":7.931653,"eighty":12.819755,"marketCap":21485677284.4},{"date":"2024-08-09","current":4.923176,"twenty":3.876246,"median":7.848551,"eighty":12.819755,"marketCap":20886419400.33},{"date":"2024-08-16","current":5.133096,"twenty":3.876246,"median":7.728514,"eighty":12.819755,"marketCap":21386096998.62},{"date":"2024-08-23","current":5.009826,"twenty":3.876246,"median":7.673113,"eighty":12.819755,"marketCap":20566937957.91},{"date":"2024-08-30","current":5.034444,"twenty":3.876246,"median":7.608478,"eighty":12.819755,"marketCap":20378972525.7},{"date":"2024-09-06","current":4.739024,"twenty":3.876246,"median":7.506908,"eighty":12.819755,"marketCap":18940304213.61},{"date":"2024-09-13","current":4.751333,"twenty":3.876246,"median":7.359171,"eighty":12.819755,"marketCap":18705266064.42},{"date":"2024-09-20","current":4.689788,"twenty":3.876246,"median":7.2022,"eighty":12.819755,"marketCap":18729179929.81},{"date":"2024-09-27","current":4.677478,"twenty":3.876246,"median":7.088216,"eighty":12.819755,"marketCap":18693431578.81},{"date":"2024-10-04","current":4.689788,"twenty":3.876246,"median":7.005747,"eighty":12.819755,"marketCap":18661799148.11},{"date":"2024-10-11","current":4.542078,"twenty":3.876246,"median":6.779635,"eighty":12.819755,"marketCap":17972116015.88},{"date":"2024-10-18","current":4.283586,"twenty":3.876246,"median":6.671286,"eighty":12.819755,"marketCap":16817039340.09},{"date":"2024-10-25","current":4.258967,"twenty":3.876246,"median":6.623283,"eighty":12.819755,"marketCap":16507746997.84},{"date":"2024-10-31","current":4.234349,"twenty":3.876246,"median":6.412714,"eighty":12.819755,"marketCap":16032080809.48},{"date":"2024-11-08","current":4.086639,"twenty":3.871856,"median":6.252461,"eighty":12.821752,"marketCap":15687984275.04},{"date":"2024-11-15","current":4.646307,"twenty":3.871856,"median":6.207587,"eighty":12.821752,"marketCap":15845911157.34},{"date":"2024-11-22","current":4.84832,"twenty":3.871856,"median":6.102881,"eighty":12.821752,"marketCap":16898815061.19},{"date":"2024-11-29","current":4.794465,"twenty":3.871856,"median":5.9533,"eighty":12.821752,"marketCap":16560180234.91},{"date":"2024-12-06","current":4.76753,"twenty":3.871856,"median":5.863552,"eighty":12.821752,"marketCap":16531483452.13},{"date":"2024-12-13","current":4.888738,"twenty":3.871856,"median":5.80372,"eighty":12.821752,"marketCap":17216536903.6},{"date":"2024-12-20","current":4.525113,"twenty":3.871856,"median":5.699013,"eighty":12.821752,"marketCap":15739882212.82},{"date":"2024-12-27","current":4.471243,"twenty":3.871856,"median":5.666965,"eighty":12.821752,"marketCap":15580193842.54},{"date":"2025-01-03","current":4.834868,"twenty":3.871856,"median":5.596128,"eighty":12.821752,"marketCap":16773742492.85},{"date":"2025-01-10","current":4.888738,"twenty":3.867466,"median":5.572516,"eighty":12.823748,"marketCap":17240401252.68},{"date":"2025-01-17","current":5.036882,"twenty":3.867466,"median":5.525012,"eighty":12.823748,"marketCap":17692127998.87},{"date":"2025-01-24","current":4.780998,"twenty":3.867466,"median":5.495776,"eighty":12.823748,"marketCap":17203435182.51},{"date":"2025-01-31","current":5.454377,"twenty":3.867466,"median":5.476216,"eighty":12.823748,"marketCap":19996471191.52},{"date":"2025-02-07","current":5.387039,"twenty":3.867466,"median":5.430705,"eighty":12.823748,"marketCap":19814319642.43},{"date":"2025-02-14","current":5.642924,"twenty":3.867466,"median":5.419036,"eighty":12.823748,"marketCap":20806134000.52},{"date":"2025-02-21","current":6.020017,"twenty":3.867466,"median":5.419036,"eighty":12.823748,"marketCap":22526244057.4},{"date":"2025-02-28","current":5.521715,"twenty":3.867466,"median":5.419036,"eighty":12.823748,"marketCap":20445151021.05},{"date":"2025-03-07","current":5.506086,"twenty":3.863076,"median":5.395151,"eighty":12.825744,"marketCap":20009097615.46},{"date":"2025-03-14","current":5.533616,"twenty":3.863076,"median":5.395151,"eighty":12.825744,"marketCap":20124812820.07},{"date":"2025-03-21","current":5.781504,"twenty":3.863076,"median":5.430568,"eighty":12.825744,"marketCap":20608888189.85},{"date":"2025-03-28","current":5.987986,"twenty":3.863076,"median":5.451025,"eighty":12.825744,"marketCap":21549111072.47},{"date":"2025-04-03","current":5.726442,"twenty":3.863076,"median":5.451025,"eighty":12.825744,"marketCap":20654669602.28}],"updateTime":1743792614719}}}